Cargando…

COBRA methods and metabolic drug targets in cancer

The identification of therapeutic strategies exploiting the metabolic alterations of malignant cells is a relevant area in cancer research. Here, we discuss a novel computational method, based on the COBRA (COnstraint-Based Reconstruction and Analysis) framework for metabolic networks, to perform th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apaolaza, Iñigo, José-Eneriz, Edurne San, Agirre, Xabier, Prósper, Felipe, Planes, Francisco J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Author's Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791858/ https://www.ncbi.nlm.nih.gov/pubmed/29404389 http://dx.doi.org/10.1080/23723556.2017.1389672

Ejemplares similares

A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism
por: Apaolaza, Iñigo, et al.
Publicado: (2022)

An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
por: Apaolaza, Iñigo, et al.
Publicado: (2017)

In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer
por: Pey, Jon, et al.
Publicado: (2017)

BOSO: A novel feature selection algorithm for linear regression with high-dimensional data
por: Valcárcel, Luis V., et al.
Publicado: (2022)

HDAC Inhibitors in Acute Myeloid Leukemia
por: San José-Enériz, Edurne, et al.
Publicado: (2019)

Explainable artificial intelligence for precision medicine in acute myeloid leukemia
por: Gimeno, Marian, et al.
Publicado: (2022)

Identifying Lethal Dependencies with HUGE Predictive Power
por: Gimeno, Marian, et al.
Publicado: (2022)

Targeting copper metabolism to defeat KRAS-driven colorectal cancer
por: Aubert, Léo, et al.
Publicado: (2020)

GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015)

DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy
por: Cheng, Xiang, et al.
Publicado: (2020)

Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015)

Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy
por: Lazear, Eric, et al.
Publicado: (2017)

Targeting one-carbon metabolism requires mTOR inhibition: a new therapeutic approach in osteosarcoma
por: Rathore, Richa, et al.
Publicado: (2021)

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
por: San José-Enériz, Edurne, et al.
Publicado: (2009)

A cancerous web: signaling, metabolism, and the epigenome
por: Lee, Joyce V., et al.
Publicado: (2014)

Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013)

On the inconsistent treatment of gene-protein-reaction rules in context-specific metabolic models
por: Ponce-de-León, Miguel, et al.
Publicado: (2019)

Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies
por: Rossig, Claudia
Publicado: (2012)

Discovering cancer immunotherapy targets in vivo
por: Zhou, Penghui, et al.
Publicado: (2014)

Mechano-regulation of proline metabolism and cancer progression by kindlin-2
por: Guo, Ling, et al.
Publicado: (2019)

Cancer cell associated glycans as targets for immunotherapy
por: Vankemmelbeke, Mireille, et al.
Publicado: (2015)

The adenosinergic system in cancer: Key therapeutic target
por: Sorrentino, Rosalinda, et al.
Publicado: (2013)

Targeting endosomal pH for cancer chemotherapy
por: Lucien, Fabrice, et al.
Publicado: (2018)

UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
por: Esteves, Pauline, et al.
Publicado: (2014)

Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
por: Priolo, Carmen, et al.
Publicado: (2015)

Linking apoptosis to cancer metabolism: Another missing piece of JuNK
por: Papa, Salvatore, et al.
Publicado: (2016)

Targeting dendritic cells in situ for breast cancer immunotherapy
por: Wang, Bei
Publicado: (2012)

Mammaglobin-A is a target for breast cancer vaccination
por: Kim, Samuel W., et al.
Publicado: (2016)

Revisiting glucose metabolism in cancer: lessons from a PKM knock-in model
por: Sato, Taku, et al.
Publicado: (2018)

Sweet connections: O-GlcNAcylation links cancer cell metabolism and survival
por: Ferrer, Christina M, et al.
Publicado: (2014)

Dual role of N-acetyl-aspartyl-glutamate metabolism in cancer monitor and therapy
por: Asaka, Ryoichi, et al.
Publicado: (2019)

HSP90 inhibitor antagonizing MIF: The specifics of pleiotropic cancer drug candidates
por: Schulz, Ramona, et al.
Publicado: (2012)

Development of interferon γ-based immunocytokines targeting renal cancer
por: Chen, Peirong, et al.
Publicado: (2013)

Targeting cancer stem cells via dendritic-cell vaccination
por: Teitz-Tennenbaum, Seagal, et al.
Publicado: (2012)

Kick-starting the cancer-immunity cycle by targeting CD40
por: Ellmark, P, et al.
Publicado: (2015)

Battling the two-headed dragon of prostate cancer targeted therapy
por: Wilkinson, Scott, et al.
Publicado: (2020)

Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology
por: Husain, Zaheed, et al.
Publicado: (2013)

Immune checkpoints: A therapeutic target in triple negative breast cancer
por: Chawla, Akhil, et al.
Publicado: (2014)

Targeted cancer immunotherapy: Mimicking physiological trans-presentation of IL-15
por: Müller, Dafne
Publicado: (2012)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u95edjlrqtf72lt4vgdpae53ir